You’re on our free tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

European Medicines Agency
EU
European Parliament
EU/Ukraine
European Commission
Eurozone
European Environment Agency
EU Summit
European Investment Bank
GDPR
European Central Bank
EU/China
Ursula von der Leyen
EU/India
EU/Russia
MEPs
Topics

Advertisement

European Medicines Agency

Share

Top Latest Popular

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

European regulators move to revoke avacopan authorization Medpage Today 3d

Medpage Today 3d

Regeneron's Applications for gMG Drug Accepted by FDA and EMA Zacks 6d

Zacks 6d

AstraZeneca's Datroway and Enhertu candidates receive EU approval ShareCast 8h

ShareCast 8h

FTSE 100 AstraZeneca

Advertisement

Advertisement

Zai Lab’s zocilurtatug pelitecan secures EMA orphan drug status Pharmaceutical Technology 09:57 Wed, 17 Jun

Pharmaceutical Technology 09:57 Wed, 17 Jun

EMA begins review of Bayer's asundexian filing for stroke prevention Zacks 16:22 Thu, 11 Jun

Zacks 16:22 Thu, 11 Jun

EMA Global Health

Yuhan secures EMA orphan drug designation for Gaucher disease candidate Korea Biomedical Review 7d

Korea Biomedical Review 7d

Advertisement

Advertisement

Latest

In the last 4 hours

Nuvation Bio Announces Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated in the United Kingdom PR Newswire (Press Release) 13:01

In the last 8 hours

AstraZeneca's Datroway and Enhertu candidates receive EU approval ShareCast 08:20

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo AbbVie (Press Release) 08:03

Friday

European Regulators Move to Revoke Avacopan Authorization Medpage Today 21:38 Fri, 26 Jun

Omeros stock crashes on regulatory setback: buy the dip? Invezz 19:14 Fri, 26 Jun

Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in Ta-Tma Business Wire (Press Release) 13:38 Fri, 26 Jun

MaaT Pharma Announces Plan to Request Re-Examination Following Negative Chmp Opinion for MaaT013 for the treatment of acute Graft-versus-Host Disease Business Wire (Press Release) 06:40 Fri, 26 Jun

Tuesday

Regeneron's Applications for gMG Drug Accepted by FDA and EMA Zacks 20:32 Tue, 23 Jun

FDA, EMA to Review Cemdisiran Regulatory Submissions in AChR-Positive Myasthenia Gravis Rare Disease Advisor 17:10 Tue, 23 Jun

Yuhan secures EMA orphan drug designation for Gaucher disease candidate Korea Biomedical Review 02:31 Tue, 23 Jun

Advertisement

Advertisement

Advertisement

Don't miss out! Get the day's top headlines delivered to your inbox

Stay informed. Sign up for a FREE NewsNow account and get our email alert of the day's top stories from the UK and around the world.

Already have an account?

By clicking 'Create Account and Subscribe' you agree to us creating an account for you and subscribing you to our newsletter in accordance with our Privacy Policy and Legal Notice.

Emails, which may be sent daily or less frequently, may include marketing elements. We will not share your email address with any third parties. You can unsubscribe whenever you want.

Advertisement

Advertisement

About our EMA news

Latest news on the European Medicines Agency, also known as the EMA, a European Union agency responsible for the evaluation and supervision of pharmaceuticals.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Europe Europe
- Back to Europe European Union
  - Ursula von der Leyen
  - Josep Borrell
  - Digital Services Act
  - ECB ECB
  - Erasmus Erasmus
  - EU Summit EU Summit
  - Europol Europol
  - Eurozone Eurozone
  - MEPs MEPs
  - European Commission
  - European Court of Justice
  - European Environment Agency
  - European Investment Bank
  - European Medicines Agency
  - European Parliament
  - Frontex Frontex
  - ETIAS ETIAS
  - GDPR GDPR
  - Global Gateway
  - Sakharov Prize
  - Schengen Schengen
  - EU/Belarus EU/Belarus
  - EU/China EU/China
  - EU/Hungary EU/Hungary
  - EU/India EU/India
  - EU/Qatar EU/Qatar
  - EU/Russia EU/Russia
  - EU/Ukraine EU/Ukraine